Related Articles
Comparison between intravenous and oral postoperative adjuvant immunochemotherapy in patients with stage III colorectal cancer
NLRC5 expression in tumors and its role as a negative prognostic indicator in stage III non-small-cell lung cancer patients
Predictive factors associated with relapse of stage II/III colon cancer treated with peroral anti‑cancer agents in the adjuvant setting
Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours
Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: Identification of responders incorporating the age factor